DYSF and neuromuscular disease caused by qualitative or quantitative defects of dysferlin: Historically, although dysferlinopathies have been under study since their initial documentation in Japan in the 1970s, our understanding of the molecular intricacies of these conditions remains elusive, largely due to the incomplete understanding of dysferlin’s core functions [22,35,36,37,38].